‘Green’ Tylenol: Synthesizing Acetaminophen from Renewable Biomass
Paracetamol (acetaminophen) is an analgesic and fever-reducing medicine. It is an active ingredient in many widely sold over-the-counter medicines such as Tylenol and Panadol. As a prescription pharmaceutical it is also sold in combination with opioid pain medications for treating more severe pain.
Introduced in the early 1900s, acetaminophen is a coal tar derivative. Today it is the most commonly used medication for pain and fever in the U.S. and on the World Health Organization’s List of Essential Medicines.
UW–Madison researchers have developed a two-step process to synthesize paracetamol (acetaminophen) from p-hydroxybenzamide, from a compound easily isolated from lignin sourced from a number of biomass species including poplar, aspen, willow and palm. P-hydroxybenzamide is produced when such biomass is treated with ammonia in the ammonia fiber expansion process (AFEX) or the extractive ammonia process (EA), or may be easily obtained from the free acid, p-hydroxybenzoic acid, from saponification.
Compared to the current industrial process, which requires the nitration and reduction of a petrochemical derivative, phenol (itself requiring a three-step process from benzene), the new method utilizes a low-cost Hofmann-type reaction to achieve this conversion. The method will work using p-hydroxybenzamide obtained from any source but biomass is preferred.
- Sustainable, cost-effective and ready to scale
- Production of high-demand pharmaceutical from renewable feedstock
- Could add value to biomass processing
The researchers have run the synthesis successfully.
For current licensing status, please contact Jennifer Gottwald at email@example.com or 608-960-9854